Deenova achieves unprecedented success with third consecutive sales record in France and strategic expansions across Italy, Norway, North Africa, and Germany

Deenova Italy Austria Belgium France Germany Netherlands Spain Switzerland United Kingdom

entered the Nordics market by winning Norway's public tender. The company is set to deliver the unit dose repackaging machine to Sjukehusapoteka Vest HF and Sykehusapotekene HF, reinforcing its commitment to advancing healthcare automation in the region.

Simultaneously, Deenova achieved another significant win in Morocco by securing the pharmacy automation service at CHU Benguerir, marking the first of its kind in the country.

As Deenova expands its European footprint, the company also strengthens its presence in established markets. In Germany, where Deenova pioneered the concept of Fully Automated Closed Loop medication management, the company secured its second customer by winning the tender of Sozialstiftung Bamberg. This accomplishment underscores Deenova's unwavering commitment and technological superiority in enhancing medication management practices.

Beyond its established presence in Italy and France, Deenova's successful internationalization cements its reputation as a trailblazer in healthcare automation. The company's status as a trusted partner in the healthcare industry is rooted in its relentless focus on innovation and customer service, currently serving nearly 100 hospitals across eight European countries.

Christophe Jaffuel, Deenova's Chief Commercial Officer, expresses satisfaction with the company's progress: "We are pleased with the continued growth and trust from our customers. Our expansion into new markets reflects the positive impact of our solutions on healthcare practices. The fully modular nature of our technological solutions allows us to offer superior adaptability to our customers' workflows, setting us apart in the industry."

Looking ahead, the company remains committed to pushing the boundaries of innovation and expanding its presence across Europe.

Deenova's unique, patented, and fully integrated solutions greatly contribute to easing healthcare providers' growing pressures to simultaneously improve patient safety, reduce therapy errors, minimize waste, contain costs, diminish the gap between rising patient volume/acuity and scarce medical staff. Deenova guarantees the simplification of the management of medications and medical devices with an expected cost savings range between 15% and 25%.

Contacts:
Christophe Jaffuel, [e-mail], 
Martina Buccianti, [e-mail], [phone]

Logo - https://mma.prnewswire.com/media/2153586/4162667/DEENOVA_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/deenova-achieves-unprecedented-success-with-third-consecutive-sales-record-in-france-and-strategic-expansions-across-italy-norway-north-africa-and-germany-302007969.html

Anzeige

Rätst du noch bei deiner Aktienauswahl oder investierst du schon nach einem profitablen System?

Ein Depot ohne klare Strategie ist im aktuellen Börsenumfeld ein unkalkulierbares Risiko. Überlass deine finanzielle Zukunft nicht länger dem Zufall oder einem vagen Bauchgefühl. Der Börsenbrief 'trading-notes' nimmt dir die komplexe Analysearbeit ab und liefert dir konkrete, überprüfte Top-Chancen. Mach Schluss mit dem Rätselraten und melde dich jetzt für 100% kostenloses Expertenwissen an.
Jetzt abonnieren .